The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022
These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements, across the United Kingdom, for the licensing, manufacture, wholesale dealing and sale or supply of human medicines for human use. The provisions in the 2012 Regulations to which the Note refers are presently due to cease to have effect on 1st April 2022.
Lifecycle
Department
Made
18 Mar 2022
—
In force
31 Mar 2022
Enabling power
In accordance with section 47(3) and (6)(c) of that Act, a draft of the instrument was laid before Parliament and the Northern Ireland Assembly, and approved by a resolution of each House of Parliament and the Northern Ireland Assembly.
DocumentsOpen on legislation.gov.uk →